115 related articles for article (PubMed ID: 17972510)
1. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
[TBL] [Abstract][Full Text] [Related]
2. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
3. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
4. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a tumour suppressive function of APRG1 in breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Breast Cancer Res Treat; 2005 Sep; 93(2):97-100. PubMed ID: 16187228
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
[TBL] [Abstract][Full Text] [Related]
7. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Zhang H; Huang CC; Tang RP
Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding proteins in human breast cancer tissue.
Pekonen F; Nyman T; Ilvesmäki V; Partanen S
Cancer Res; 1992 Oct; 52(19):5204-7. PubMed ID: 1382838
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
Voskuil DW; Bosma A; Vrieling A; Rookus MA; van 't Veer LJ
Breast Cancer Res Treat; 2004 Apr; 84(3):225-33. PubMed ID: 15026620
[TBL] [Abstract][Full Text] [Related]
13. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma.
Shao ZM; Sheikh MS; Ordonez JV; Feng P; Kute T; Chen JC; Aisner S; Schnaper L; LeRoith D; Roberts CT
Cancer Res; 1992 Sep; 52(18):5100-3. PubMed ID: 1381277
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
15. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
16. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
Peterson BC; Waldbieser GC
Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization, tissue distribution patterns and nutritional regulation of IGFBP-1, -2, -3 and -5 in yellowtail, Seriola quinqueradiata.
Pedroso FL; Fukada H; Masumoto T
Gen Comp Endocrinol; 2009 May; 161(3):344-53. PubMed ID: 19523384
[TBL] [Abstract][Full Text] [Related]
18. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
19. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity.
Probst-Hensch NM; Steiner JH; Schraml P; Varga Z; Zürrer-Härdi U; Storz M; Korol D; Fehr MK; Fink D; Pestalozzi BC; Lütolf UM; Theurillat JP; Moch H
Clin Cancer Res; 2010 Feb; 16(3):1025-32. PubMed ID: 20103684
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel insulin-like growth factor binding protein gene homologue with tumor suppressor like properties.
Cai Z; Chen HT; Boyle B; Rupp F; Funk WD; Dedera DA
Biochem Biophys Res Commun; 2005 May; 331(1):261-6. PubMed ID: 15845387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
